UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007339
Receipt number R000007729
Scientific Title Parital clamping of infrahepatic inferior vena cava for reduction of blood loss during hepatectomy
Date of disclosure of the study information 2012/02/20
Last modified on 2016/02/23 16:21:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Parital clamping of infrahepatic inferior vena cava for reduction of blood loss during hepatectomy

Acronym

IVC partial-clamp study

Scientific Title

Parital clamping of infrahepatic inferior vena cava for reduction of blood loss during hepatectomy

Scientific Title:Acronym

IVC partial-clamp study

Region

Japan


Condition

Condition

liver cancer

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and safety of infrahepatic inferior vena cava partial clamping for reducing blood loss during hepatectomy.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Phase III


Assessment

Primary outcomes

Blood loss during surgery

Key secondary outcomes

Postoperative complications, change of circulating blood volume, blood loss during hepatic parenchimal resection, operating time


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Partial clamping of infrahepatic inferior vena cava

Interventions/Control_2

Conventional method

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1) Patients with performance status 0-2.
2) Patients with Child-Pugh grade A.
3) Patients with well maintained bone marrow and renal functions.
a) White blood cell count: 3000-12000/mm3
b) Platelet count:>=70000/mm3
c) Hemoglobin:>=10.0g/dL
d) Serum creatinine:=<1.5mg/dL
4) Central venous pressure is >=5mmHg before hepatic parenchyma resection.
5) Patients who gave written informed consent prior to the study.

Key exclusion criteria

1) Patients underwent upper abdominal surgery formerly.
2) Patients need vascular reconstruction.
3) Patients with severe cardiac dysfunction (NYHA classificaion grade III or more) or atrial fibrillation or tricuspid regurgitation.
4) Patients with deep vein thrombosis.
5) Patients with severe COPD.
6) Patients underewnt artificial dialysis.

Target sample size

90


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ueno Masaki

Organization

Wakayama medical university

Division name

Sencond department of sugery

Zip code


Address

811-1 Kimidera, Wakayama City

TEL

073-447-2300

Email

ma@wakayama-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Ueno Masaki

Organization

Wakayama medical university

Division name

Sencond department of sugery

Zip code


Address

811-1 Kimidera, Wakayama City

TEL

073-447-2300

Homepage URL


Email

ma@wakayama-med.ac.jp


Sponsor or person

Institute

Wakayama medical university

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

和歌山県立医科大学


Other administrative information

Date of disclosure of the study information

2012 Year 02 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 08 Month 01 Day

Date of IRB


Anticipated trial start date

2011 Year 08 Month 01 Day

Last follow-up date

2015 Year 11 Month 30 Day

Date of closure to data entry

2015 Year 11 Month 30 Day

Date trial data considered complete

2015 Year 12 Month 31 Day

Date analysis concluded

2016 Year 01 Month 31 Day


Other

Other related information



Management information

Registered date

2012 Year 02 Month 20 Day

Last modified on

2016 Year 02 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007729


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name